2014 - Understanding Combination Products, Requests for Designation and Product Jurisdiction
Date2014-08-14
Deadline2014-08-14
VenueOnline Event, USA - United States
KeywordsCompliance Training; Regulatory Training; Pharma; Clinical; Health
Websitehttps://bit.ly/1ogZzNG
Topics/Call fo Papers
Overview:
This webinar will provide a detailed discussion of understanding the definition of a combination product, the categories of combination products, how combination products are reviewed, how to assemble a request for designation (RFD) and how to work with FDA when submitting applications for combination products. To do this it will reference the extensive information provided by FDA's Office of Combination Products.
Why Should you Attend:
You should attend because understanding how combination products are reviewed by FDA is critical to avoiding costly and time-consuming mistakes with respect to which part of FDA will have the primary jurisdiction for a given combination product. Understanding how FDA determines the primary jurisdiction for a combination product (i.e., which Center will be the lead Center for review of the application) will allow companies to have the most appropriate information in the submission and know who their primary contacts in FDA will be.
Areas Covered in the Session:
Definition of a combination product
Categories of combination products
How combination products are reviewed
How to assemble a request for designation (RFD)
How to work with FDA when submitting applications for combination products
Who Will Benefit:
Regulatory Affairs Professionals
Staff with responsibility for preclinical testing of medical devices
All companies developing
Manufacturing and Marketing medical devices in the US
Quick Contact:
GlobalCompliancePanel
USA Phone:800-447-9407
Fax: 302-288-6884
webinars-AT-globalcompliancepanel.com
http://www.globalcompliancepanel.com
This webinar will provide a detailed discussion of understanding the definition of a combination product, the categories of combination products, how combination products are reviewed, how to assemble a request for designation (RFD) and how to work with FDA when submitting applications for combination products. To do this it will reference the extensive information provided by FDA's Office of Combination Products.
Why Should you Attend:
You should attend because understanding how combination products are reviewed by FDA is critical to avoiding costly and time-consuming mistakes with respect to which part of FDA will have the primary jurisdiction for a given combination product. Understanding how FDA determines the primary jurisdiction for a combination product (i.e., which Center will be the lead Center for review of the application) will allow companies to have the most appropriate information in the submission and know who their primary contacts in FDA will be.
Areas Covered in the Session:
Definition of a combination product
Categories of combination products
How combination products are reviewed
How to assemble a request for designation (RFD)
How to work with FDA when submitting applications for combination products
Who Will Benefit:
Regulatory Affairs Professionals
Staff with responsibility for preclinical testing of medical devices
All companies developing
Manufacturing and Marketing medical devices in the US
Quick Contact:
GlobalCompliancePanel
USA Phone:800-447-9407
Fax: 302-288-6884
webinars-AT-globalcompliancepanel.com
http://www.globalcompliancepanel.com
Other CFPs
- Excel Spreadsheet Validation for FDA 21 CFR Part 11
- ICH GCPs and the Clinical Research Process (Including Phase 0,1,2,3 and Phase 4 trials)
- Customer Interactions: Law, Policies, Ethics
- Key Concepts in Successful Water System Sanitization
- 2014 IEEE International Conference on Control Science and Systems Engineering (CCSSE 2014)
Last modified: 2014-07-07 15:31:19